Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Whitener MEB, Stanstrup J, Carlin S, Divol B, Du Toit M, Vrhovsek U
There is no FDA-approved generic semaglutide as of 2026 because the manufacturer holds active patents on the brand-name formulations
Important safety considerations include the risk of acute pancreatitis (seek urgent medical advice for severe, persistent abdominal pain), gallbladder disease, dehydration leading to acute kidney injury from gastrointestinal effects, and potential worsening of diabetic retinopathy with rapid improvement in blood glucose control
Tirzepatide (Mounjaro, ZepBound): This dual-action medication mimics both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP, another naturally occurring hormone), resulting in even greater weight loss for many people
